NASDAQ:XRAY - DENTSPLY SIRONA Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $50.56
  • Forecasted Upside: 39.66 %
  • Number of Analysts: 10
  • Breakdown:
  • 0 Sell Ratings
  • 6 Hold Ratings
  • 4 Buy Ratings
  • 0 Strong Buy Ratings
$36.20
▲ +0.47 (1.32%)

This chart shows the closing price for XRAY by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New DENTSPLY SIRONA Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for XRAY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for XRAY

Analyst Price Target is $50.56
▲ +39.66% Upside Potential
This price target is based on 10 analysts offering 12 month price targets for DENTSPLY SIRONA in the last 3 months. The average price target is $50.56, with a high forecast of $0.00 and a low forecast of $0.00. The average price target represents a 39.66% upside from the last price of $36.20.

This chart shows the closing price for XRAY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Hold

The current consensus among 10 investment analysts is to hold stock in DENTSPLY SIRONA. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 6 buy ratings
  • 8 hold ratings
  • 1 sell ratings
1/10/2021
  • 0 strong buy ratings
  • 5 buy ratings
  • 7 hold ratings
  • 1 sell ratings
4/10/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 6 hold ratings
  • 1 sell ratings
7/9/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 4 hold ratings
  • 1 sell ratings
10/7/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 3 hold ratings
  • 1 sell ratings
1/5/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 4 hold ratings
  • 0 sell ratings
4/5/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings
6/4/2022
  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings
7/4/2022

Latest Recommendations

  • 0 strong buy ratings
  • 4 buy ratings
  • 6 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
6/1/2022UBS GroupUpgradeNeutral ➝ Buy$58.00 ➝ $47.00High
5/11/2022Barrington ResearchLower Price Target$53.00 ➝ $51.00Medium
4/22/2022HC WainwrightLower Price TargetHold$58.00 ➝ $48.00Medium
4/21/2022The Goldman Sachs GroupLower Price TargetNeutral$59.00 ➝ $47.00Medium
4/20/2022Morgan StanleyLower Price TargetOverweight$62.00 ➝ $52.00Low
4/20/2022Barrington ResearchLower Price Target$72.00 ➝ $53.00High
4/20/2022Piper SandlerReiterated RatingOverweight ➝ Neutral$71.00 ➝ $46.00Medium
4/19/2022Bank of AmericaDowngradeBuy ➝ Neutral$66.00 ➝ $49.00High
4/19/2022William BlairDowngradeOutperform ➝ Market PerformHigh
4/19/2022Robert W. BairdDowngradeOutperform ➝ Neutral$67.00 ➝ $48.00High
3/1/2022The Goldman Sachs GroupLower Price TargetNeutral$66.00 ➝ $59.00High
3/1/2022Barrington ResearchLower Price Target$79.00 ➝ $72.00High
3/1/2022Credit Suisse GroupLower Price TargetOutperform$68.00 ➝ $67.00High
3/1/2022HC WainwrightLower Price Target$66.00 ➝ $58.00Low
2/18/2022Robert W. BairdLower Price TargetOutperform$78.00 ➝ $67.00High
1/31/2022Morgan StanleyInitiated CoverageOverweight$62.00Low
8/9/2021HC WainwrightLower Price TargetNeutral$72.00 ➝ $66.00Low
8/6/2021Barrington ResearchBoost Price TargetOutperform$77.00 ➝ $79.00Low
5/7/2021Barrington ResearchBoost Price TargetOutperform$71.00 ➝ $77.00Low
5/7/2021Robert W. BairdBoost Price TargetOutperform$71.00 ➝ $78.00Medium
5/7/2021HC WainwrightBoost Price TargetNeutral$60.00 ➝ $72.00Medium
5/6/2021Piper SandlerBoost Price TargetOverweight$70.00 ➝ $75.00Medium
3/2/2021BarclaysBoost Price TargetUnderweight$50.00 ➝ $55.00Medium
3/2/2021Robert W. BairdBoost Price TargetOutperform$62.00 ➝ $71.00Medium
3/2/2021Barrington ResearchUpgradeMarket Perform ➝ Outperform$71.00Medium
3/2/2021HC WainwrightReiterated RatingNeutral$55.00 ➝ $60.00Low
3/1/2021Piper SandlerBoost Price TargetOverweight$63.00 ➝ $70.00Low
1/5/2021Robert W. BairdBoost Price TargetOutperform$58.00 ➝ $62.00N/A
1/5/2021BarclaysBoost Price TargetUnderweight$40.00 ➝ $44.00N/A
1/5/2021HC WainwrightBoost Price TargetNeutral$49.00 ➝ $55.00N/A
12/18/2020Stifel NicolausDowngradeBuy ➝ Hold$52.00Low
12/15/2020Piper SandlerBoost Price TargetOverweight$51.00 ➝ $61.00High
11/17/2020BarclaysDowngradeEqual Weight ➝ Underweight$40.00Low
11/9/2020HC WainwrightBoost Price TargetNeutral$45.00 ➝ $49.00High
10/22/2020GuggenheimUpgradeNeutral ➝ BuyHigh
10/5/2020JPMorgan Chase & Co.Boost Price TargetNeutral$45.00 ➝ $47.00Medium
8/10/2020HC WainwrightLower Price TargetNeutral$50.00 ➝ $45.00Low
7/20/2020Bank of AmericaBoost Price TargetBuy$54.00 ➝ $56.00Medium
6/16/2020Piper SandlerInitiated CoverageOverweight$51.00Low
6/15/2020HC WainwrightBoost Price TargetNeutral$38.00 ➝ $50.00Medium
5/27/2020Evercore ISIUpgradeIn-Line ➝ Outperform$50.00High
5/14/2020CfraLower Price TargetHold$53.00 ➝ $38.00High
5/11/2020BarclaysLower Price TargetEqual Weight$42.00 ➝ $40.00High
5/11/2020UBS GroupLower Price TargetNeutral$59.00 ➝ $44.00High
5/11/2020Barrington ResearchDowngradeOutperform ➝ Market PerformLow
4/24/2020HC WainwrightLower Price TargetNeutral$51.00 ➝ $38.00Medium
4/19/2020Credit Suisse GroupReiterated RatingBuy$50.00Low
4/19/2020Robert W. BairdUpgradeNeutral ➝ OutperformLow
4/8/2020Robert W. BairdUpgradeNeutral ➝ Outperform$57.00 ➝ $49.00Medium
4/7/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$58.00 ➝ $40.00Medium
4/2/2020Wolfe ResearchUpgradePeer Perform ➝ Outperform$66.00Low
3/17/2020JPMorgan Chase & Co.Lower Price TargetNeutral$65.00 ➝ $45.00High
3/13/2020Stifel NicolausLower Price TargetBuy$66.00 ➝ $56.00Low
3/11/2020The Goldman Sachs GroupDowngradeConviction-Buy ➝ BuyLow
3/3/2020Barrington ResearchLower Price TargetOutperform$63.00 ➝ $60.00Medium
3/3/2020Robert W. BairdLower Price TargetNeutral$61.00 ➝ $57.00High
3/3/2020HC WainwrightReiterated RatingNeutral$60.00 ➝ $51.00High
2/19/2020Stifel NicolausBoost Price TargetBuy$63.00 ➝ $66.00Medium
1/19/2020BarclaysReiterated RatingHold$64.00Medium
12/11/2019JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$65.00Low
11/15/2019HC WainwrightReiterated RatingHold$60.00Low
8/5/2019Barrington ResearchReiterated RatingBuy$63.00High
8/2/2019Wellington ShieldsUpgradeHold ➝ Gradually AccumulateHigh
7/26/2019Evercore ISIInitiated CoverageIn-line ➝ In-LineLow
7/9/2019HC WainwrightReiterated RatingNeutral ➝ Neutral$55.00 ➝ $57.00Low
5/30/2019Wolfe ResearchInitiated CoveragePeer Perform ➝ Peer PerformLow
5/6/2019Barrington ResearchUpgradeMarket Perform ➝ Outperform$63.00Medium
5/6/2019HC WainwrightReiterated RatingNeutral ➝ Neutral$49.00 ➝ $55.00Low
4/17/2019GuggenheimInitiated CoverageNeutral ➝ Neutral$54.00High
4/5/2019HC WainwrightSet Price TargetHold$49.00Low
3/18/2019Bank of AmericaInitiated CoverageBuy$57.00Low
3/18/2019William BlairUpgradeMarket Perform ➝ Outperform$56.71Medium
3/12/2019UBS GroupBoost Price TargetNeutral ➝ Neutral$42.00 ➝ $53.00Low
3/4/2019Robert W. BairdBoost Price TargetNeutral ➝ Neutral$42.00 ➝ $50.00Medium
3/4/2019HC WainwrightReiterated RatingNeutral ➝ Neutral$40.00 ➝ $49.00Low
3/1/2019William BlairUpgradeMarket Perform ➝ OutperformLow
3/1/2019BarclaysSet Price TargetHold$49.00Low
1/17/2019UBS GroupInitiated CoverageNeutral ➝ Neutral$42.00Low
1/6/2019BarclaysReiterated RatingHold$39.00Medium
11/9/2018Barrington ResearchReiterated RatingHoldMedium
10/19/2018The Goldman Sachs GroupUpgradeSell ➝ Buy$44.00High
8/31/2018HC WainwrightSet Price TargetHold$40.00Medium
8/9/2018Barrington ResearchDowngradeOutperform ➝ Market PerformLow
8/8/2018BarclaysLower Price TargetEqual Weight ➝ Equal Weight$55.00 ➝ $41.00Medium
8/8/2018Jefferies Financial GroupLower Price TargetBuy ➝ Buy$58.00 ➝ $46.00Medium
8/8/2018Stifel NicolausLower Price TargetBuy ➝ Buy$57.00 ➝ $46.00Medium
8/8/2018HC WainwrightReiterated RatingHold$40.00Medium
8/8/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$54.00 ➝ $40.00Medium
8/8/2018StephensDowngradeOverweight ➝ Equal Weight$75.00Medium
8/7/2018Robert W. BairdDowngradeOutperform ➝ Neutral$56.00 ➝ $38.00High
6/14/2018Morgan StanleyLower Price TargetOverweight ➝ Overweight$65.00 ➝ $54.00Low
6/5/2018Northcoast ResearchDowngradeBuy ➝ NeutralHigh
5/16/2018Deutsche Bank AktiengesellschaftLower Price TargetBuy$55.00Low
5/8/2018Robert W. BairdLower Price TargetOutperform ➝ Outperform$71.00High
5/8/2018Barrington ResearchLower Price TargetOutperform ➝ Outperform$70.00 ➝ $54.00High
5/8/2018BarclaysReiterated RatingHold$55.00High
5/8/2018Stifel NicolausReiterated RatingBuy ➝ Buy$67.00 ➝ $57.00High
5/8/2018HC WainwrightLower Price TargetNeutral ➝ Neutral$63.00 ➝ $52.00High
4/16/2018Jefferies Financial GroupReiterated RatingBuyLow
4/5/2018Cleveland ResearchReiterated RatingHoldLow
3/27/2018Barrington ResearchReiterated RatingBuy$69.00Medium
3/27/2018HC WainwrightSet Price TargetHold$63.00Medium
3/8/2018BarclaysInitiated CoverageEqual Weight ➝ Equal Weight$62.00Low
3/5/2018JPMorgan Chase & Co.Lower Price TargetOverweight ➝ Overweight$75.00 ➝ $70.00Low
3/5/2018Barrington ResearchReiterated RatingOutperform ➝ Outperform$73.00 ➝ $70.00Low
3/5/2018HC WainwrightSet Price TargetNeutral ➝ Hold$68.00 ➝ $63.00Medium
3/2/2018Credit Suisse GroupLower Price TargetOutperform ➝ Outperform$73.00 ➝ $69.00High
1/18/2018HC WainwrightReiterated RatingHold$68.00Low
1/5/2018Credit Suisse GroupDowngradeHold$73.00Medium
12/13/2017JPMorgan Chase & Co.UpgradeNeutral ➝ Overweight$75.00Medium
12/8/2017Deutsche Bank AktiengesellschaftInitiated CoverageBuy ➝ Buy$81.00Low
12/7/2017HC WainwrightReiterated RatingHold$68.00Low
11/30/2017HC WainwrightDowngradeBuy ➝ Neutral$68.00Medium
11/28/2017StephensInitiated CoverageOverweight$75.00Low
11/6/2017Stifel NicolausBoost Price TargetBuy$66.00 ➝ $70.00N/A
11/6/2017HC WainwrightReiterated RatingBuy$68.00N/A
11/6/2017Barrington ResearchUpgradeMarket Perform ➝ Outperform$73.00N/A
10/19/2017Robert W. BairdSet Price TargetBuy$63.00N/A
10/19/2017Stifel NicolausReiterated RatingBuyN/A
10/6/2017Morgan StanleyReiterated RatingOverweight$67.00 ➝ $69.00N/A
10/5/2017Cleveland ResearchDowngradeBuy ➝ NeutralN/A
10/3/2017HC WainwrightReiterated RatingBuy$68.00Low
8/23/2017Jefferies Financial GroupLower Price TargetBuy$72.00 ➝ $66.00High
8/14/2017HC WainwrightReiterated RatingBuy ➝ Buy$74.00 ➝ $68.00Medium
8/10/2017UBS GroupReiterated RatingNeutral$62.00 ➝ $59.00Low
8/10/2017Morgan StanleyBoost Price TargetOverweight$66.00 ➝ $67.00Low
8/10/2017Stifel NicolausReiterated RatingBuy$70.00 ➝ $66.00Low
7/13/2017Credit Suisse GroupReiterated RatingOutperform$67.00 ➝ $75.00Low
7/11/2017HC WainwrightInitiated CoverageBuy ➝ Buy$74.00Low
(Data available from 7/5/2017 forward)

News Sentiment Rating

0.20 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 17 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
12/6/2021
  • 1 very positive mentions
  • 4 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
1/5/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
2/4/2022
  • 7 very positive mentions
  • 9 positive mentions
  • 4 negative mentions
  • 0 very negative mentions
3/6/2022
  • 1 very positive mentions
  • 22 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
4/5/2022
  • 3 very positive mentions
  • 20 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/5/2022
  • 8 very positive mentions
  • 39 positive mentions
  • 5 negative mentions
  • 4 very negative mentions
6/4/2022
  • 2 very positive mentions
  • 10 positive mentions
  • 5 negative mentions
  • 1 very negative mentions
7/4/2022

Current Sentiment

  • 2 very positive mentions
  • 10 positive mentions
  • 5 negative mentions
  • 1 very negative mentions

Recent Stories by Sentiment

DENTSPLY SIRONA logo
DENTSPLY SIRONA Inc. designs, develops, manufactures, distributes, and sells various dental products and technologies for professional dental market worldwide. It offers dental equipment, including treatment centers, imaging equipment, motorized dental handpieces, and other instruments; imaging equipment; treatment centers comprising basic dentist chairs, sophisticated chair-based units with integrated diagnostic, hygiene and ergonomic functionalities, and specialist centers; and lab equipment, such as amalgamators, mixing machines, and porcelain furnaces. The company also provides dental CAD/CAM products, digital impressions intraoral scanners, mills, and services; and orthodontic products, including high frequency vibration technology device under the name VPro, dentist-directed clear aligner solutions under the name SureSmile, and direct-to-consumer clear aligner solutions under the name Byte; dental implant products, bone regenerative and restorative solutions, and educational programs; and urology catheters and other healthcare-related consumable products. In addition, it offers endodontic products comprising endodontic instruments and materials, drills, filers, sealers, irrigation needles, and other tools or single-use solutions; restorative products that include dental prosthetics, such as artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products; small equipment products comprise intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers; and dental supplies, including dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. The company was formerly known as DENTSPLY International Inc. and changed its name to DENTSPLY SIRONA Inc. in February 2016. DENTSPLY SIRONA Inc. was founded in 1899 and is headquartered in Charlotte, North Carolina.
Read More

Today's Range

Now: $36.20
Low: $35.34
High: $36.25

50 Day Range

MA: $38.32
Low: $34.74
High: $41.95

52 Week Range

Now: $36.20
Low: $33.78
High: $66.98

Volume

65,360 shs

Average Volume

2,284,170 shs

Market Capitalization

$7.80 billion

P/E Ratio

21.42

Dividend Yield

1.38%

Beta

0.94

Frequently Asked Questions

What sell-side analysts currently cover shares of DENTSPLY SIRONA?

The following Wall Street research analysts have issued research reports on DENTSPLY SIRONA in the last twelve months: Bank of America Co., Barrington Research, Credit Suisse Group AG, HC Wainwright, Morgan Stanley, Piper Sandler, Robert W. Baird, StockNews.com, The Goldman Sachs Group, Inc., TheStreet, UBS Group AG, and William Blair.
View the latest analyst ratings for XRAY.

What is the current price target for DENTSPLY SIRONA?

0 Wall Street analysts have set twelve-month price targets for DENTSPLY SIRONA in the last year. Their average twelve-month price target is $50.56, suggesting a possible upside of 39.7%.
View the latest price targets for XRAY.

What is the current consensus analyst rating for DENTSPLY SIRONA?

DENTSPLY SIRONA currently has 6 hold ratings and 4 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in XRAY, but not buy more shares or sell existing shares.
View the latest ratings for XRAY.

How do I contact DENTSPLY SIRONA's investor relations team?

DENTSPLY SIRONA's physical mailing address is 13320 BALLANTYNE CORPORATE PLACE, CHARLOTTE NC, 28277. The medical instruments supplier's listed phone number is (844) 848-0137 and its investor relations email address is [email protected] The official website for DENTSPLY SIRONA is www.dentsplysirona.com. Learn More about contacing DENTSPLY SIRONA investor relations.